Technology and disease burden shape demand, but product type, application and end-use setting determine where growth is concentrated in the rapid medical diagnostic kits market. According to Polaris Market Research, the market is projected to rise from USD 34.6 billion in 2025 to USD 57.6 billion by 2034, registering a CAGR of 5.80% from 2025 to 2034, after a 2024 valuation of USD 32.7 billion.

Professional and Over-the-Counter Products

By product, the market is divided into professional and over-the-counter (OTC) kits. The professional segment accounts for the largest share because these laboratory-focused kits provide high specificity and sensitivity for effective disease diagnosis, and they are widely recognized as the gold standard in research applications for their efficacy and safety. The over-the-counter segment has nonetheless shown significant potential in revenue share. OTC kits are used in offices, schools and home care, offering a cost-effective and convenient alternative to laboratory testing with quick disease diagnosis. These rapid kits are readily available and provide instant disease diagnosis.

Application Breadth

Application segmentation covers nine categories, including lipid profile testing, blood glucose testing, toxicology testing, infectious disease testing, coagulation testing, cardiometabolic testing, fecal occult blood testing, pregnancy and fertility testing and others. Glucose management in particular is attracting innovation. In March 2025, Phani Kumar Praturi introduced a framework that integrates predictive analytics with Continuous Glucose Monitoring systems to support real-time diabetes management, and in February 2025 researchers at the National Institute of Technology Rourkela developed an AI-based model to improve blood glucose predictions.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/rapid-medical-diagnostic-kits-market

Hospitals, Clinics and Homes

By end use, the market includes three settings: home care, hospitals & clinics and diagnostic laboratories. The hospitals & clinics segment is expected to witness the fastest CAGR during the forecast period, primarily because primary care settings within hospitals use these kits extensively to diagnose and treat diseases. Hospitals and clinics are major hubs for healthcare services, which makes them a major adopter, and diagnostic laboratories complete the end-use segmentation. The home care segment is also expected to grow significantly, supported by the rising trend of immediate diagnosis and monitoring of patients’ health conditions at home. This convenience and accessibility have increased demand for kits in home settings.

Regional Analysis

North America accounted for the largest share in 2024 owing to the high prevalence of diseases, particularly diabetes, and growing awareness and patient demand. Abbott introduced its Afinion HbA1c Dx test in June 2019 to aid diagnosis of diabetic patients. Asia Pacific is projected to grow at the fastest CAGR during the forecast period as key regional players introduce new testing kits to provide comprehensive rapid diagnosis services. In March 2020, Singapore-based Biolidics introduced its 2019-nCoV IgG/IgM quick kit for COVID-19 after receiving approval from Singapore’s Health Science Authority.

Report Scope and Coverage

The report covers the market by product, technology, application, end use and region, spanning North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. Revenue is presented in USD billion, with 2024 as the base year, historical data from 2020 to 2023 and a forecast period of 2025 to 2034. Customization by country, region and segmentation is available.

Competitive Insight

The market is characterized by intense competition, with established players relying on advanced technology, high-quality products and a strong brand image to drive revenue growth. These companies use research and development, mergers and acquisitions, and technological innovation to expand their product portfolios and maintain a competitive edge.

Key Players in the Rapid Medical Diagnostic Kits Market

•         Abbott Laboratories

•         ACON Laboratories, Inc.

•         Alfa Scientific Designs, Inc.

•         Artron Laboratories Inc.

•         Becton

•         bioMérieux SA

•         Bio-Rad Laboratories, Inc.

•         Cardinal Health

•         Creative Diagnostics

•         Danaher Corporation

•         Dickinson and Company

•         F. BTNX, Inc.

•         Hoffmann-La Roche AG

•         McKesson Medical-Surgical, Inc.

•         Meridian Bioscience, Inc.

•         Sight Diagnostics Ltd

•         Trinity Biotech

•         Zoetis

Conclusion

Across product types, applications and end-use settings, the rapid medical diagnostic kits market shows how accessibility drives adoption. Professional kits retain the leading share, while over-the-counter formats, home care use and hospitals & clinics broaden access. Application breadth, from blood glucose testing to pregnancy and fertility testing, supports steady demand as the market advances toward USD 57.6 billion by 2034.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market